JUNIPER BIOLOGICS ACQUIRES CELL-MEDIATED GENE THERAPY TG-C LD FOR TREATMENT OF KNEE OSTEOARTHRITIS ...Middle East

$600 million USD acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa SINGAPORE, April 12, 2022 /PRNewswire/ -- Juniper Biologics, a science-led healthcare company focused on...

Hence then, the article about juniper biologics acquires cell mediated gene therapy tg c ld for treatment of knee osteoarthritis was published today ( Wednesday 13/04/2022 - 02:43 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( JUNIPER BIOLOGICS ACQUIRES CELL-MEDIATED GENE THERAPY TG-C LD FOR TREATMENT OF KNEE OSTEOARTHRITIS )

Also on site :

• Olympic Gymnastics Legend, Who Scored the World’s First Perfect 10, Relives Her Greatest Performance 50 Years Later
• ABBA’s Björn Ulvaeus Talks AI Training at United Nations Summit: Artists ‘Deserve a Place at the Table’
• Dunkin' Donuts Is Giving Away Free Drinks on July 14 for 1 Hour Only